Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults.
Mulligan MJ, Russell ND, Celum C, Kahn J, Noonan E, Montefiori DC, Ferrari G, Weinhold KJ, Smith JM, Amara RR, Robinson HL; NIH/NIAID/DAIDS HIV Vaccine Trials Network. Mulligan MJ, et al. Among authors: noonan e. AIDS Res Hum Retroviruses. 2006 Jul;22(7):678-83. doi: 10.1089/aid.2006.22.678. AIDS Res Hum Retroviruses. 2006. PMID: 16831092 Clinical Trial.
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Gorse GJ, Baden LR, Wecker M, Newman MJ, Ferrari G, Weinhold KJ, Livingston BD, Villafana TL, Li H, Noonan E, Russell ND; HIV Vaccine Trials Network. Gorse GJ, et al. Among authors: noonan e. Vaccine. 2008 Jan 10;26(2):215-23. doi: 10.1016/j.vaccine.2007.10.061. Epub 2007 Nov 20. Vaccine. 2008. PMID: 18055072 Clinical Trial.
DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults.
Gorse GJ, Newman MJ, deCamp A, Hay CM, De Rosa SC, Noonan E, Livingston BD, Fuchs JD, Kalams SA, Cassis-Ghavami FL; NIAID HIV Vaccine Trials Network. Gorse GJ, et al. Among authors: noonan e. Clin Vaccine Immunol. 2012 May;19(5):649-58. doi: 10.1128/CVI.00038-12. Epub 2012 Mar 7. Clin Vaccine Immunol. 2012. PMID: 22398243 Free PMC article. Clinical Trial.
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults.
Jin X, Newman MJ, De-Rosa S, Cooper C, Thomas E, Keefer M, Fuchs J, Blattner W, Livingston BD, McKinney DM, Noonan E, Decamp A, Defawe OD, Wecker M; NIAID HIV Vaccine Trials Network. Jin X, et al. Among authors: noonan e. Vaccine. 2009 Nov 23;27(50):7080-6. doi: 10.1016/j.vaccine.2009.09.060. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786145 Free PMC article. Clinical Trial.
Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study.
Koblin BA, Mayer KH, Noonan E, Wang CY, Marmor M, Sanchez J, Brown SJ, Robertson MN, Buchbinder SP. Koblin BA, et al. Among authors: noonan e. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):405-13. doi: 10.1097/QAI.0b013e31825325aa. J Acquir Immune Defic Syndr. 2012. PMID: 22421748 Free PMC article. Clinical Trial.
Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study.
Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, O'Cleirigh C, Chesney MA, Coates TJ, Koblin BA, Mayer KH. Mimiaga MJ, et al. Among authors: noonan e. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):340-8. doi: 10.1097/QAI.0b013e3181a24b38. J Acquir Immune Defic Syndr. 2009. PMID: 19367173 Free PMC article. Clinical Trial.
Concurrence of Eosinophilic Esophagitis and Dyshidrotic Eczema.
Noonan E, Suozzi N, Smith AD, Lyons CE, Borish L, Barnes B, Zlotoff BJ, McGowan EC. Noonan E, et al. Dermatitis. 2023 Nov 21. doi: 10.1089/derm.2023.0177. Online ahead of print. Dermatitis. 2023. PMID: 38011020 No abstract available.
Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind-body survivorship program.
Finkelstein-Fox L, Bliss CC, Rasmussen AW, Hall DL, El-Jawahri A, Perez GK, Traeger LN, Comander AH, Peppercorn J, Anctil R, Noonan E, Park ER. Finkelstein-Fox L, et al. Among authors: noonan e. Support Care Cancer. 2023 Oct 6;31(10):616. doi: 10.1007/s00520-023-08062-1. Support Care Cancer. 2023. PMID: 37801182
86 results